Bowel resection can be done for many diseases that affect the colon, such as colorectal cancer, diverticulitis, or Crohn's disease. The goal of bowel resection is to take out the part of the colon or ...

Cold endoscopic mucosal resection (EMR) demonstrates lower rates of delayed bleeding and perforation but a higher risk for recurrent or residual neoplasia than hot EMR in colorectal polyp treatment.

Bowel resection can be done for many diseases that affect the colon, such as colorectal cancer, diverticulitis, or Crohn's disease. The goal of bowel resection is to take out the part of the colon or ...

Shares of Biodexa Pharmaceuticals skyrocketed nearly 50% on Monday, hitting their highest level since early December. The ...

Investigators included adults with Dukes' C or high-risk Dukes' B colon cancer or Dukes' B or C rectal cancer who completed resection and at least three months of chemotherapy. Patients were ...

Last month, the company commenced enrolment in the Phase III SAGITTARIUS trial, aiming to evaluate the Signatera test in personalising adjuvant treatment strategies for stage III and high-risk stage ...

This section is about surgery for cancer that starts in the large bowel (colon cancer) that hasn't spread to another part of the body. Local resection is for small, early stage colon cancers. Your ...

The modified intention-to-treat analysis included 1,550 colorectal cancer patients who had undergone resection and had completed standard adjuvant therapy (at least 3 months of chemotherapy).

Systematic literature review (SLR) of prognostic factors (PFs) in locally advanced rectal cancer (LARC) and mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) rectal cancer (RC).

DNA testing may inform treatment decisions and predict outcomes of adjuvant chemotherapy in patients with stage II-III colorectal cancer.

Despite recent advances in therapy, certain subtypes of colorectal cancer, such as those that are microsatellite instability ...